PHARMACOECONOMICS ANALYSIS OF TREATMENT OF METASTATIC COLORECTAL CANCER WITH BEVACIZUMAB IN BRAZIL

被引：0
|
作者：
Tonon, L. M. [1 ]
Secoli, S. R. [2 ]
机构：
[1] Hosp Sirio Libanes, Sao Paulo, Brazil
[2] Univ Fed Sao Paulo, Sao Paulo, Brazil
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)75350-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A497 / A497
页数：1
相关论文
共 50 条
  • [21] Immunological Effects of Bevacizumab-Based Treatment in Metastatic Colorectal Cancer
    Manzoni, M.
    Rovati, B.
    Ronzoni, M.
    Loupakis, F.
    Mariucci, S.
    Ricci, V.
    Gattoni, E.
    Salvatore, L.
    Tinelli, C.
    Villa, E.
    Danova, M.
    ONCOLOGY, 2010, 79 (3-4) : 187 - 196
  • [22] BEVACIZUMAB AS 4TH LINE TREATMENT IN METASTATIC COLORECTAL CANCER
    Cannella, Lucia
    Carlomagno, Chiara
    De Stefano, Alfonso
    Alfieri, Salvatore
    Colantuoni, Maria
    Cella, Chiara
    De Placido, Sabino
    ANNALS OF ONCOLOGY, 2009, 20 : 17 - 18
  • [23] Cost-effectiveness analysis of bevacizumab combined with chemotherapy for the treatment of metastatic colorectal cancer in Japan
    Shiroiwa, Takeru
    Fukuda, Takashi
    Tsutani, Kiichiro
    CLINICAL THERAPEUTICS, 2007, 29 (10) : 2256 - 2267
  • [24] Hypertension as a predictive biomarker for efficacy of bevacizumab treatment in metastatic colorectal cancer: A meta-analysis
    Chen, Cui
    Sun, Peng
    Ye, Sheng
    Weng, Hui-wen
    Dai, Qiang-sheng
    JOURNAL OF BUON, 2014, 19 (04): : 917 - 924
  • [25] Bevacizumab in the treatment of colorectal cancer
    Mulcahy, MF
    Benson, A
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (07) : 997 - 1005
  • [26] Bevacizumab for Metastatic Colorectal Cancer: A Global Cost-Effectiveness Analysis
    Goldstein, Daniel A.
    Chen, Qiushi
    Ayer, Turgay
    Chan, Kelvin K. W.
    Virik, Kiran
    Hammerman, Ariel
    Brenner, Baruch
    Flowers, Christopher R.
    Hall, Peter S.
    ONCOLOGIST, 2017, 22 (06): : 694 - 699
  • [27] Bevacizumab in the treatment of colorectal cancer
    Cilley, Jeffrey C.
    Barfi, Keren
    Benson, Al B., III
    Mulcahy, Mary F.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (05) : 739 - 749
  • [28] FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer REPLY
    Cremolini, Chiara
    Loupakis, Fotios
    Falcone, Alfredo
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (03): : 291 - 292
  • [29] Bevacizumab in elderly patients with metastatic colorectal cancer
    Sclafani, Francesco
    Cunningham, David
    JOURNAL OF GERIATRIC ONCOLOGY, 2014, 5 (01) : 78 - 88
  • [30] FOLFOXIRI plus Bevacizumab in metastatic colorectal Cancer
    不详
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020, 58 (07): : 630 - 630
12345